The overall incidence of hemangioblastoma within the skull is not too high, but it is not uncommon in this specific part of the posterior cranial fossa. Although the most common site of growth for hemangioblastoma is the cerebellum, it can occasionally grow in the spinal cord, brainstem, and cerebrum. Because hemangioblastoma grows in the cerebellum and compresses the cerebellar tissue, symptoms of increased intracranial pressure and abnormal cerebellar function, such as headaches, vomiting, nausea, unsteady walking, and balance disturbances, occur. Among intracranial tumors, tumors with the word “mother” in their names are not good, basically they are malignant tumors, such as glioblastoma, astrocytoma, medulloblastoma, etc. These tumors grow fast, and even if surgical resection is performed together with radiotherapy, they are easy to recur or even metastasize, making it difficult to be truly cured. It is difficult to cure. However, hemangioblastoma is an exception. Hemangioblastoma is a benign tumor, which can be completely cured by surgical resection. Hemangioblastoma is often a cystic solid lesion, and by completely removing the substantial nodules during surgery, it can be treated by surgical resection alone without the need for subsequent radiotherapy. A recently completed case of hemangioblastoma is such a case, the patient is a 52-year-old female patient, the operation is relatively simple, the lesion removal only needs ten minutes, the patient was discharged from the hospital in less than one week after the operation. However, a case of completely substantial cerebellar hemangioblastoma completed last year was not so simple. The patient was a 31-year-old male who was found to have a completely substantial hemangioblastoma on the right side of the cerebellum because of a headache, and the magnetic resonance angiography before the operation revealed that the blood supply of the lesion was very rich, so the operation was divided into two steps. First, a vascular embolization procedure was performed to partially block the blood supply to the lesion and reduce the risk of massive hemorrhagic shock during the craniotomy; and then a craniotomy was performed 3 days later to completely remove the lesion. After the planned staged surgery, although bleeding from the lesion during the craniotomy was still significant, it was greatly reduced compared to the surgery without embolization, and the patient recovered quickly after the surgery. This type of fully substantial hemangioblastoma of relatively large size is much more difficult and risky to operate on if it is located in the brainstem. Of course, not all hemangioblastomas can be cured by brain surgery. About 20% of hemangioblastomas of the brain or spinal cord are part of vonHippel-Lindau disease, which may be associated with pancreatic tumors, renal cell carcinomas, and pheochromocytomas, which require a multidisciplinary approach.